AIMOVIG
NDC 55513-841, erenumab-aooe, injection, from Amgen, Inc.
- Product NDC
- 55513-841
- Status
- Listed
- Labeler
- Amgen, Inc
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761077
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55513-841 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ERENUMAB70 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55513-841-00 | 55513084100 | 2 SYRINGE, GLASS in 1 CARTON (55513-841-00) / 1 mL in 1 SYRINGE, GLASS |
| 55513-841-01 | 55513084101 | 1 SYRINGE, GLASS in 1 CARTON (55513-841-01) / 1 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b998ed05-94b0-47fd-b28f-cddd1e128fd8NADAC price for package 55513084101
GET /v1/drugs/nadac/55513084101
Use it
Look up 55513-841 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55513-841 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55513-841. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.